Rayence Co

Rayence Co Current Liabilities

The Current Liabilities of Rayence Co (228850.KQ) as of Nov 14, 2026 is 6.36 B KRW. In the previous year, Current Liabilities was 8.77 B KRW — a change of -27.40% (lower).

Current Liabilities

6.36 BKRW

YoY

-27.40%

Last updated:

Current Liabilities of Rayence Co is 2025 6.36 B KRW. Current Liabilities of Rayence Co was 2024 8.77 B KRW. It decreases by -27.40% lower compared to the previous year.

The Rayence Co Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
17.21 B KRW
Jan 1, 2019
23.76 B KRW
Jan 1, 2020
19.58 B KRW
Jan 1, 2021
27.04 B KRW
Jan 1, 2022
31.72 B KRW
Jan 1, 2023
10.06 B KRW
Jan 1, 2024
8.77 B KRW
Jan 1, 2025
6.36 B KRW
The Rayence Co Current Liabilities history
YEARCurrent LiabilitiesYoY
6.36 BKRW-27.40%
8.77 BKRW-12.87%
10.06 BKRW-68.28%
31.72 BKRW+17.27%
27.04 BKRW+38.10%
19.58 BKRW-17.58%
23.76 BKRW+38.09%
17.21 BKRW-2.45%
17.64 BKRW-14.01%
20.51 BKRW+30.84%
15.68 BKRW-29.54%
22.25 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Current Liabilities of Rayence Co is 6.36 B KRW in 2025.

Current Liabilities of Rayence Co changed from 8.77 B KRW to 6.36 B KRW, representing a -27.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Rayence Co since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Rayence Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rayence Co

All Key Metrics — Rayence Co